#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Colon cancer Mantle cell lymphoma stage III Follicular lymphoma stage II Metastatic gastric cancer Osteochondrodysplasia Arterial disorder Hyperphagia Soft tissue sarcoma Chronic graft versus host disease B-cell lymphoma recurrent Progressive familial intrahepatic cholestasis Leiomyosarcoma Vaginal cancer Keratosis follicular Primary immunodeficiency syndrome More trials…

    Learn about Rare Diseases

    Toxic epidermal necrolysis – Trials in Disease Retinoblastoma – Basic Information Turner’s syndrome – Life with Disease Lennox-Gastaut syndrome – Diagnostics Primary biliary cholangitis – Life with Disease Primary biliary cholangitis – Treatment Haemolytic uraemic syndrome – Life with Disease Piriformis syndrome – Basic Information Brain stem glioma Brain stem glioma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sodium Lactate Solution Oteracil Rbl027.2 Chlortalidone CITRIC ACID ANHYDROUS Metoclopramide Hydrochloride Azd0305 Inavolisib Rucaparib GRNA-001 Sumatriptan Succinate GSKVX000000025896 Tebipenem Pivoxil Hydrobromide Thiamine ULTEVURSEN Star-0215 Wt1/Il15/Il15Ra Mrna Dc Tominersen Gefitinib Felis Domesticus (555) More therapies…

    Learn about Your Condition

    Radiation skin injury Tumour thrombosis Peritonitis Enteritis Hodgkin's disease Complex regional pain syndrome Incisional hernia Eye disorder Leiomyosarcoma recurrent Testis cancer Adrenoleukodystrophy Vesicoureteric reflux Myelofibrosis Ocular hypertension Post-traumatic headache More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut Jules Bordet

Institut Jules Bordet

Mijlenmeersstraat 90, Anderlecht, 1070, Belgium

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Lacutamab Alone or with Chemotherapy for Patients with Advanced T-Cell Lymphoma

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Cutaneous T-cell lymphoma
    • Cutaneous T-cell lymphoma recurrent
    Investigated Drugs:
    • Lacutamab
    Belgium France Germany Italy Poland Spain

  • Study of JK08, Pembrolizumab, and Lenvatinib for Patients with Advanced or Metastatic Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Adenocarcinoma gastric
    • Adenocarcinoma pancreas
    • Cervix carcinoma
    Investigated Drugs:
    • Jk08
    • Lenvatinib
    • Pembrolizumab
    Belgium Spain

  • Study on the Effectiveness and Safety of CAEL-101 with Drug Combination for Patients with Advanced AL Amyloidosis

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Anselamimab
    • Sodium Chloride Ph. Eur.
    • Sodium Hydrogen Carbonate Pheur
    Austria Belgium Czechia France Germany Greece +3

  • Study Comparing Asciminib with Other Drug Combinations for Adults with Newly Diagnosed Chronic Myeloid Leukemia

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic myeloid leukaemia
    Investigated Drugs:
    • Asciminib Hydrochloride
    • Bosutinib
    • Dasatinib
    Austria Belgium Bulgaria Czechia Denmark Finland +9

  • Study on Ibrutinib, CD20 Ab and Venetoclax for Patients with Untreated Mantle Cell Lymphoma

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Mantle cell lymphoma
    Investigated Drugs:
    • Ibrutinib
    • Obinutuzumab
    • Rituximab
    Belgium France

  • Study Comparing Trastuzumab Deruxtecan and Trastuzumab Emtansine for Patients with Advanced HER2-Positive Breast Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    • HER2 positive breast cancer
    Investigated Drugs:
    • Trastuzumab Deruxtecan
    • Trastuzumab Emtansine
    Belgium France Italy Spain

  • Study of MK-2870 for Patients with Advanced or Metastatic Stomach Cancer, Comparing Its Effects to a Drug Combination

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Buclizine Hydrochloride
    • Codeine Phosphate
    • Docetaxel
    Belgium Denmark France Germany Italy Poland +1

  • Study of Pembrolizumab with Chemotherapy for Patients with Gastric or Gastroesophageal Junction Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Adenocarcinoma gastric
    • Oesophageal adenocarcinoma
    Investigated Drugs:
    • Calcium Folinate
    • Capecitabine
    • Cisplatin
    Belgium Estonia France Germany Italy Latvia +2

  • Study of Tarlatamab for Patients with Limited-Stage Small-Cell Lung Cancer After Chemoradiotherapy

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Argipressin
    • Betamethasone Sodium Phosphate
    • Buclizine Hydrochloride
    Austria Belgium Bulgaria France Germany Greece +6

  • Study of Paclitaxel, Carboplatin, and Durvalumab with or without Oleclumab for Patients with Untreated Advanced Triple-Negative Breast Cancer

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    • Breast cancer recurrent
    • Triple negative breast cancer
    Investigated Drugs:
    • Carboplatin
    • Durvalumab
    • Oleclumab
    Belgium France
Previous Page
1 … 15 16 17 18 19 … 22
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!